Original paper

Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The Netherlands

Volume: 32, Issue: 3, Pages: 119 - 130
Published: Jan 26, 2016
Abstract
Severe infection of infants with respiratory syncytial virus (RSV) is a leading cause of morbidity in the developed world and mortality in the developing world. Prophylaxis using palivizumab in infants at risk for severe RSV disease reduces the rate of hospitalisation in this population of children. To ensure complete prophylaxis, infants must receive monthly doses over the winter season. To improve parental convenience, the Synacare® programme...
Paper Details
Title
Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The Netherlands
Published Date
Jan 26, 2016
Volume
32
Issue
3
Pages
119 - 130
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.